For over 50 years, Ziehm Imaging has been at the forefront of developing advanced technologies that enhance medical imaging and optimize clinical workflows. Our mobile C-arm solutions deliver outstanding image quality, reduced X-ray dose, and user-friendly operation. By continuously setting new standards in X-ray-based imaging, we drive innovation that improves patient care and transforms lives around the world. | For over 50 years, Ziehm Imaging technologies enhance imaging and streamline clinical workflows. Our technology provides innovative solutions for improved image quality, minimized X-ray dose and unparalleled ease-of-use. By setting new technological standards in X-ray-based imaging solutions with our mobile C-arms, we are leading innovations and changing lives all over the world.
Viz.AI
Viz.ai is the leading platform, leveraging artificial intelligence and machine learning to improve clinical care and accelerate treatments and technology. The Viz Platform is a transformative solution that uses artificial intelligence to unify synchronized care collaboration, high fidelity mobile image viewing, real-time patient information and secure communication to optimize workflows for better patient care coordination. Viz.ai’s comprehensive vascular portfolio includes care coordination products for detection of suspected pulmonary embolism with automated RV/LV ratio and aortic disease. These solutions leverage advanced deep learning to communicate time-sensitive information about patients straight to a specialist who can intervene and treat. Viz is the most comprehensive and effective AI platform that is already helping to coordinate care across a broad list of clinical applications in more than 1,800 hospitals. | Viz.ai is the leading platform, leveraging artificial intelligence and machine learning to improve clinical care and accelerate treatments and technology. The Viz Platform is a transformative solution that uses AI to unify care collaboration. | Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,800+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One® is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit Viz.ai.
UF Health Shands
The University of Florida’s Pulmonary, Critical Care, Lung Transplant, and Thoracic Programs form one of the nation’s premier destinations for complex lung and airway disease. As a high-volume referral center, UF provides advanced care for patients with the most challenging medical and surgical needs, including highly HLA-sensitized individuals, those requiring ECMO support, patients with multi-organ dysfunction, and adults or children needing lung or multi-organ transplantation. UF’s Pulmonary Vascular Disease Center and Rare Lung Disease Program delivers nationally recognized expertise across pulmonary arterial hypertension, hereditary hemorrhagic telangiectasia, lymphangioleiomyomatosis, and pulmonary alveolar proteinosis, each supported by accreditation as a Center of Excellence from leading national foundations. Integrated closely with thoracic surgery and cutting-edge research teams, these programs collectively drive innovation in diagnosis, therapeutics, and multidisciplinary care, establishing UF as a leading hub for advanced lung disease and transformative respiratory medicine.
Thirona
Thirona provides advanced lung image analysis with artificial intelligence through expertise-based services for MedTech, pharmaceutical and CRO companies. Thirona’s lung quantification platform LungQ® consists of a comprehensive portfolio of robust high-performance algorithms trained on a wide range of disease-specific datasets, offering market-leading AI analytical capabilities, with consistent and reproducible results. Integrated in multiple certified clinical end-products, our software is used by clinicians in more than 600 hospitals worldwide.
Strados Labs
Strados Labs is a medical technology company focused on improving the lives of patients with respiratory diseases. Enabling remote monitoring of lung health, Strados Labs’ RESP Biosensor allows clinicians to continuously measure patients’ lung sounds such as cough and wheeze that can indicate an exacerbation or reduced quality of life. The technology is used to assist drug developers in demonstrating treatment efficacy in clinical trials and to support clinicians in disease surveillance and management. The RESP Biosensor is FDA-cleared, CE marked and HIPAA compliant, backed by multiple awards and clinical publications. Strados Labs is privately owned and based in Philadelphia, PA.
Rhythm Healthcare
Rhythm Healthcare is a market leader in respiratory and durable medical equipment (DME), recognized for its portfolio of best-in-class, reliable oxygen concentrators. Focused on continuous innovation, engineering excellence, and unparalleled customer support, Rhythm Healthcare is committed to empowering patients with mobility and independence while offering industry-leading products and the robust Rhythm Resolve brand-new replacement warranty program to its HME provider partners.
Pulmonary Hypertension Association
Headquartered in Washington, D.C., the Pulmonary Hypertension Association is the oldest and largest nonprofit patient association dedicated to the pulmonary hypertension community. PHA’s mission is to extend and improve the lives of those affected by PH. Through support, advocacy and awareness, education, quality care and research programs, PHA empowers patients, caregivers, families, health care professionals and researchers worldwide. Our 2026 PHA International PH Conference and Scientific Sessions will take place on June 11-14, 2026 in Dallas.
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn. | Verona Pharma is a subsidiary of Merck& Co, Inc.,(Rahway, New Jersey, USA). For more information, please visit www.veronapharma.com. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. | We aspire to be the premier research-intensive biopharmaceutical company | We aspire to be the premier research-intensive biopharmaceutical company. Our purpose: We use the power of leading-edge science to help save and improve lives around the world For more than 130 years, and since 1911 in Canada, Merck has brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
Intuitive Surgical
At Intuitive®, innovating for minimally invasive care is the passion that drives us. Our robotic-assisted da Vinci® Surgical System helps empower doctors and hospitals to make surgery less invasive than an open approach. | At Intuitive®, innovating for minimally invasive care is the passion that drives us. The Ion endoluminal system is Intuitive’s robotic-assisted platform for minimally invasive biopsy in the lung. We built Ion on the belief that collecting lung tissue samples for biopsy could be safe and simple, even when nodules are small and located in the peripheral lung. Ion’s ultrathin, ultramaneuverable catheter allows clinicians to reach small lesions in all 18 segments of the lung.